Evaluation of HER2 and p53 expression in predicting response to docetaxel-based first-line chemotherapy in advanced breast cancer von Camerini, Andrea, Donati, Sara, Viacava, Paolo, Siclari, Olimpia, Puccetti, Cheti, Tartarelli, Gianna, Valsuani, Chiara, De Luca, Filomena, Martini, Leonardo, Cavazzana, Andrea, Amoroso, Domenico

Volltext

Targeting triple negative breast cancer: Is p53 the answer? von Turner, Natalie, Moretti, Erica, Siclari, Olimpia, Migliaccio, Ilenia, Santarpia, Libero, D’Incalci, Maurizio, Piccolo, Stefano, Veronesi, Andrea, Zambelli, Alberto, Del Sal, Gianni, Di Leo, Angelo

Volltext

Fulvestrant treatment is associated with cholesterol plasma level reduction in hormone receptor-positive metastatic breast cancer patients von Camerini, Andrea, Rondini, Marianna, Garrone, Ornella, Valsuani, Chiara, Donati, Sara, Siclari, Olimpia, Sgambato, Alessandro, Tartarelli, Gianna, Vincenti, Maura, Polla Mattiot, Valentina, Prosperi Porta, Romana, Puccetti, Cheti, Puccinelli, Paolo, Amoroso, Domenico

Volltext

Early triple negative breast cancer: Are we getting better outcomes? A retrospective analysis from a single institution von Barchiesi, Giacomo, McCartney, Amelia, Biagioni, Chiara, Siclari, Olimpia, Rossi, Lorenzo, Pestrin, Marta, Di Leo, Angelo, Biganzoli, Laura

Volltext

Defining optimal duration and predicting benefit from chemotherapy in patients with luminal-like subtypes von Hart, Christopher D, Sanna, Giuseppina, Siclari, Olimpia, Biganzoli, Laura, Di Leo, Angelo

Volltext

p95HER2 Truncated Form in Resected Non-small Cell Lung Cancer von Cappuzzo, Federico, Cho, Yong Gon, Sacconi, Andrea, Alì, Greta, Siclari, Olimpia, Incarbone, Matteo, Destro, Annarita, Terracciano, Luigi, Fontanini, Gabriella, Marchetti, Antonio, Roncalli, Massimo, Varella-Garcia, Marileila

Volltext

The continued evidence from overviews: What is the clinical utility? von Turner, Natalie, Biganzoli, Laura, Malorni, Luca, Migliaccio, Ilenia, Moretti, Erica, Pestrin, Marta, Sanna, Giuseppina, Siclari, Olimpia, Di Leo, Angelo

Volltext

Expression of dystroglycan correlates with tumor grade and predicts survival in renal cell carcinoma von Sgambato, A., Camerini, A., Amoroso, D., Genovese, G., De Luca, F., Cecchi, M., Migaldi, M., Rettino, A., Valsuani, C., Tartarelli, G., Donati, S., Siclari, O., Rossi, G., Cittadini, A.

Volltext

Adjuvant chemotherapy: which patient? What regimen? von Turner, Natalie, Biganzoli, Laura, Malorni, Luca, Migliaccio, Ilenia, Moretti, Erica, Pestrin, Marta, Sanna, Giuseppina, Siclari, Olimpia, Di Leo, Angelo

Volltext

Adjuvant Chemotherapy: Which Patient? What Regimen? von Turner, Natalie, Biganzoli, Laura, Malorni, Luca, Migliaccio, Ilenia, Moretti, Erica, Pestrin, Marta, Sanna, Giuseppina, Siclari, Olimpia, Di Leo, Angelo

Volltext

Sorafenib in a patient with advanced hepatocellular carcinoma and serious impairment of left ventricular function: a case report von Valsuani, Chiara, Siclari, Olimpia, Camerini, Andrea, Canale, Maria Laura, Rondini, Marianna, Donati, Sara, Puccinelli, Paolo, Tartarelli, Gianna, Puccetti, Cheti, Amoroso, Domenico

Volltext